Ctrl K
Last 24 quarters of trend data · Healthcare · Medical - Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.02 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 1.47 | — | — | — | 6.54 | 10.63 | 5.45 | 0.78 | 1.02 | 0.93 | 1.37 | 1.86 | 1.82 | 4.88 | 2.01 | 64.51 | 125.03 | 151.02 | 155.31 | 301.12 | — |
| — | — | — | — | +540.1% | +1042.3% | +297.0% | -57.8% | -44.0% | -80.9% | -31.8% | -97.1% | -98.5% | -96.8% | -98.7% | -78.6% | — | — | — | — | — | |
| P/B Ratio | 0.00 | 0.15 | 0.23 | 0.02 | 0.68 | 0.99 | 0.50 | 0.22 | 0.18 | 0.12 | 0.85 | 0.74 | 0.36 | 0.99 | 0.58 | 29.00 | 41.33 | 38.96 | 23.97 | 33.22 | — |
| — | -85.1% | -54.1% | -88.9% | +275.9% | +697.8% | -41.0% | -70.0% | -49.1% | -87.5% | +46.4% | -97.4% | -99.1% | -97.4% | -97.6% | -12.7% | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -1.3% | — | — | 100.0% | -99.3% | 62.8% | 71.4% | -132.8% | 34.9% | 21.4% | 50.0% | 0.8% | 38.3% | 37.9% | 30.1% | 10.5% | 13.2% | 23.7% | 16.4% | -6.8% | -9.4% |
| — | — | — | +175.3% | -384.4% | +193.0% | +42.9% | -15901.2% | -8.8% | -43.4% | +66.4% | -92.0% | +190.0% | +60.0% | +83.8% | +254.3% | +240.7% | +292.3% | +140.1% | +69.1% | +68.2% | |
| Operating Margin | -2067.5% | — | — | 654.0% | -1700.7% | -2248.8% | -2151.4% | -857.2% | -1135.7% | -861.4% | -443.4% | -628.6% | -624.1% | -1319.9% | -562.8% | -552.9% | -541.7% | -571.6% | -523.6% | -626.0% | -443.7% |
| — | — | — | +176.3% | -49.7% | -161.1% | -385.2% | -36.4% | -82.0% | +34.7% | +21.2% | -13.7% | -15.2% | -130.9% | -7.5% | +11.7% | -22.1% | -45.2% | -60.0% | -188.5% | +46.2% | |
| Net Margin | -2324.1% | — | — | 943.4% | -1778.1% | -2245.3% | -2145.7% | -820.6% | -1135.7% | -904.3% | -443.4% | -628.3% | -624.1% | -1319.9% | -562.8% | -552.7% | -541.5% | -571.6% | -523.1% | -1017.5% | -837.5% |
| — | — | — | +215.0% | -56.6% | -148.3% | -383.9% | -30.6% | -82.0% | +31.5% | +21.2% | -13.7% | -15.3% | -130.9% | -7.6% | +45.7% | +35.3% | -40.0% | -24.6% | -237.9% | -2.0% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -91.8% | -61.9% | -44.5% | -25.5% | -56.0% | -57.4% | -53.9% | -55.0% | -40.7% | -39.9% | -51.7% | -48.0% | -39.4% | -50.8% | -47.9% | -48.0% | -37.0% | -31.3% | -18.4% | -99.6% | — |
| — | -7.8% | +17.4% | +53.7% | -37.4% | -44.0% | -4.4% | -14.6% | -3.3% | +21.4% | -7.9% | -0.1% | -6.6% | -62.3% | -160.6% | +51.8% | — | — | — | — | — | |
| ROA | -51.6% | -20.1% | -17.8% | -15.1% | -48.4% | -46.6% | -45.6% | -47.6% | -35.0% | -31.4% | -34.7% | -36.6% | -30.3% | -36.3% | -32.3% | -31.7% | -26.9% | -25.4% | -16.1% | -43.8% | -102.8% |
| — | +56.9% | +61.1% | +68.4% | -38.2% | -48.6% | -31.5% | -30.2% | -15.4% | +13.6% | -7.5% | -15.4% | -13.0% | -42.8% | -99.8% | +27.6% | +73.9% | +56.2% | +83.5% | +40.0% | — | |
| ROIC | -106.4% | -23.7% | -26.8% | -23.2% | -80.2% | -59.6% | -77.9% | -196.5% | -187.6% | -138.6% | -163.3% | -215.1% | -133.8% | -211.8% | -267.6% | -512.7% | — | -617.6% | -170.7% | — | — |
| — | +60.2% | +65.5% | +88.2% | +57.3% | +57.0% | +52.3% | +8.6% | -40.2% | +34.5% | +39.0% | +58.1% | — | +65.7% | -56.8% | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.38 | 0.84 | 1.54 | 0.38 | — | — | — | — | — | — | 0.15 | 0.10 | 0.07 | 0.15 | 0.10 | 0.15 | 0.10 | 0.08 | 0.06 | 0.05 | — |
| — | — | — | — | — | — | — | — | — | — | +53.7% | -29.4% | -27.5% | +88.8% | +60.2% | +173.7% | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 20.13 | 1.11 | 3.31 | 20.13 | 5.86 | 2.24 | 1.70 | 9.70 | 5.65 | 7.89 | 2.79 | 3.32 | 6.46 | 3.45 | 4.12 | 2.51 | 3.75 | 4.36 | 10.94 | 11.72 | 0.25 |
| — | -50.5% | +94.4% | +107.5% | +3.8% | -71.6% | -39.0% | +192.2% | -12.5% | +128.8% | -32.3% | +32.1% | +72.0% | -20.9% | -62.3% | -78.5% | +1401.8% | +975.6% | +1566.5% | +898.4% | — | |
| Quick Ratio | 20.13 | 0.86 | 3.02 | 20.13 | 5.86 | 1.90 | 1.29 | 8.53 | 4.34 | 6.59 | 2.01 | 2.78 | 5.53 | 2.60 | 3.52 | 2.05 | 3.38 | 4.01 | 10.53 | 11.37 | 0.20 |
| — | -54.5% | +134.5% | +136.0% | +34.8% | -71.2% | -35.8% | +206.7% | -21.4% | +153.9% | -43.0% | +35.3% | +63.6% | -35.3% | -66.6% | -81.9% | +1605.0% | +1044.9% | +1907.2% | +1054.2% | — | |
| Interest Coverage | -53.75 | -9.30 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -23.50 | -1.05 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 24 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying TIVC stock.
Tivic Health Systems, Inc.'s current P/E is -0.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Tivic Health Systems, Inc.'s current operating margin is -2067.5%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Tivic Health Systems, Inc.'s business trajectory between earnings reports.